Showing results (461-470 of 492) with videos related to
Sort By:
Pageof 50
NPJ Breast Cancer|July 19, 2022
TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospectsKojo Agyemang, Allan M Johansen, Grayson W Barker, et al.Nature Cell Biology|January 30, 2019
SETDB1-mediated methylation of Akt promotes its K63-linked ubiquitination and activation leading to tumorigenesisGuihua Wang, Jie Long, Yuan Gao, et al.Blood|May 10, 2021
Myeloid lncRNA LOUP mediates opposing regulatory effects of RUNX1 and RUNX1-ETO in t(8;21) AMLBon Q Trinh, Simone Ummarino, Yanzhou Zhang, et al.Cancer Discovery|March 10, 2017
Cabozantinib Eradicates Advanced Murine Prostate Cancer by Activating Antitumor Innate ImmunityAkash Patnaik, Kenneth D Swanson, Eva Csizmadia, et al.Oncotarget|December 7, 2017
Danshen improves survival of patients with advanced lung cancer and targeting the relationship between macrophages and lung cancer cellsChing-Yuan Wu, Jong-Yuh Cherng, Yao-Hsu Yang, et al.Cell|May 29, 2012
The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, herceptin sensitivity, and tumorigenesisChia-Hsin Chan, Chien-Feng Li, Wei-Lei Yang, et al.Biomolecules|October 3, 2020
Identification of Plasma Glycosphingolipids as Potential Biomarkers for Prostate Cancer (PCa) StatusAshley J Snider, Michael C Seeds, Laurel Johnstone, et al.Plos One|December 20, 2012
Deletion of TAK1 in the myeloid lineage results in the spontaneous development of myelomonocytic leukemia in miceBetty Lamothe, Yunju Lai, Lana Hur, et al.Human Molecular Genetics|September 1, 2018
Loss of LDAH associated with prostate cancer and hearing lossBenjamin B Currall, Ming Chen, Richard C Sallari, et al.The Journal of Clinical Investigation|November 9, 2013
KDM2A promotes lung tumorigenesis by epigenetically enhancing ERK1/2 signalingKlaus W Wagner, Hunain Alam, Shilpa S Dhar, et al.Pageof 50